Friday 6 November 2026
Export AGL’s income statement to Excel — free account
Agilon Health, Inc.
AGL Healthcare Medical Care Facilities
Agilon Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, down 2.11% from fiscal 2024.
- Revenue
- +5.86%
- EPS
- +130.8%
- Free cash flow
- +234.4%
- Total debt
- −12.7%
Quarter to September 2026, against a year earlier
108.53
5.24
−4.61%
Follow AGL
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 4 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 2 | 4 | — |
| (130.95%) | (104.02%) | (72.97%) | (29.68%) | ||
| (26.04%) | (20.63%) | (14.06%) | (5.51%) | ||
ROIC |
0.00% | 0.00% | (34,218.16%) | 0.00% | |
Return on Tangible Assets |
(857.67%) | (480.83%) | (177.67%) | (45.72%) | |
Average Days of Receivables |
41.45 | 56.42 | 65.34 | 61.83 | |
Free Cash Flow per Share |
(8.99) | (5.14) | (6.34) | (1.01) | |
Free Cash Flow |
(148.87) | (85.40) | (105.98) | (17.01) | |
Capital Expenditures |
(43.11) | (35.35) | (33.72) | (12.77) | |
| Other line items | |||||
Cash ROIC |
(33.31%) | (16.60%) | (20.58%) | (2.73%) | |
Accounts Receivable Turnover |
7.02 | 5.44 | 5.62 | 6.11 | |
Accounts Payable Turnover |
35.03 | 27.80 | 26.44 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | — | |
Average Days of Payables |
7.64 | 12.39 | 16.99 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | — | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.05 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
4.02% | 3.90% | 4.38% | 4.50% | |
Share Based Compensation of Revenue |
0.83% | 0.66% | 0.80% | 0.97% | |
Interest Coverage |
(69.75) | (63.01) | (44.36) | (22.38) | |
Operating CF/Net income |
0.27 | 0.14 | 0.31 | 0.05 | |
Depreciation/Fixed assets |
1.13 | 1.15 | 1.14 | 1.14 | |
Capex/Depreciation |
(1.51) | (1.24) | (1.20) | (0.47) | |
Revenue per Share |
358.27 | 350.64 | 354.39 | 357.54 | |
Operating CF per Share |
(6.39) | (3.02) | (4.33) | (0.25) | |
Capex per Share |
(2.60) | (2.13) | (2.02) | (0.76) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.00 |
Columns are period end dates · fundamentals updated 4 Nov 2026